Edit Content
Get in touch
🔬 Presented at SBRT-2025 & ICBRAR Conference, IMS-BHU

India's Clinical AMR Intelligence + Phage Therapy Platform

Transforming fragmented surveillance into actionable clinical decisions in hours, not days. Bridging research labs, hospitals, and national authorities with AI-powered pathogen-phage matching.

TRL 5-6 | MVP validation in progress | Actively seeking pilot collaborators

Real-time Pathogen Analysis

Interactive dashboard with live matching algorithms

95%
Accuracy
3-6h
Response Time
100+
Cases
AMR CRISIS OVERVIEW

India's AMR Crisis Demands Systematic Solutions

297,000 deaths annually

Highest global AMR burden (WHO, NCDC 2023)

Fragmented surveillance

60 NARS-Net labs operate in silos with no clinical integration

Manual workflows

24+ hours from culture to clinical decision

Phage therapy bottleneck

Only 3 active clinical phage labs; no systematic matching platform

12

Research institutions

2

Hospital pilot sites

100+

Clinical cases processed

3-6 hrs

Decision time (target)

OUR SOLUTION

PhageMatch Platform

A unified platform connecting hospitals, labs, phage scientists, and national authorities

📊

WHONET-Compatible Data Engine

Instantly ingests resistance profiles from 60+ NARS-Net labs using standard formats. Eliminates manual data entry and standardization bottlenecks.

🤖

AI/ML Pathogen-Phage Matching

Evidence-based algorithmic matching for E. coli, Klebsiella, MRSA based on susceptibility profiles. Transparent reasoning, clinician-review workflows.

🏥

Multi-Stakeholder Dashboards

Role-based views for clinicians (treatment recommendations), lab directors (compliance reporting), researchers (validation datasets).

⚖️

Compliance Automation

NCDC, ICMR, SAPCAR, EQAS-ready reporting. Audit trails and secure data governance for regulatory requirements.

🔄

Integrated Clinical Workflow

Hospital → Lab (WHONET data) → PhageMatch AI/ML → Matching library → Treatment decision → Outcome tracking → National repository. Feedback loop for continuous model improvement.

KEY DIFFERENTIATORS

Why PhageMatch Stands Alone

🏆

First Clinical-Research Bridge in India

No existing platform integrates AMR surveillance labs with clinical decision-making AND phage therapy matching. PhageMatch bridges this critical gap.

🔗

NARS-Net Native

Built for India's existing surveillance infrastructure. WHONET compatibility means instant adoption without replacing current systems.

📋

Regulatory-Ready Architecture

Designed from the ground up for DISHA compliance, HIPAA-equivalent security, audit trails, and national reporting requirements.

🔍

Evidence-Based, Not Black-Box

Clinicians see why matching recommendations are made. Rule-based inference transitioning to validated ML models with published papers.

📡

Offline-Capable

Works in resource-limited settings with unreliable connectivity. Designed for Indian healthcare infrastructure realities.

🎯

Purpose-Built for Phage Therapy

Not a generic AMR tool. Phage library management, bacterial strain matching, treatment protocols integrated end-to-end.

VALIDATION & TRUST

Validation in Progress

Active clinical collaboration with institutional partners. Published validation pipeline.

Pilot Metrics

95% Pathogen-Phage Matching Accuracy

Validated across 100+ pilot cases (peer review in progress)

90% Clinician Satisfaction

Early adopter feedback from pilot hospitals

3-6 Hour Decision Time

vs. 24+ hour manual workflow baseline

Security & Compliance

DISHA Compliance Framework

HIPAA-equivalent security standards for patient data

IRB/Ethics Approvals

Underway at pilot hospital sites; data governance protocols established

Audit Trail & Role-Based Access

Built for NCDC/ICMR regulatory audit requirements

📄

Scientific Validation

Partnership with leading research institutions for phage library validation. Preparing manuscripts on clinical outcomes, matching algorithm accuracy, and workflow integration results.

PARTNERSHIP OPPORTUNITIES

Join Our Validation & Growth Journey

PhageMatch is at TRL 5-6, moving from MVP validation toward scaled clinical deployment.

🏥

Hospital Pilot Partners

Looking for 3-5 tertiary care hospitals (ICU focus) to expand pilot cohort from 2 to 500+ patient cases.

  • Real-world clinical validation
  • Workflow integration testing
  • Compliance framework refinement
🔬

Phage Library Partners

Seeking collaboration with clinical phage research labs to expand matching library and validate therapeutic efficacy.

  • Phage characterization support
  • Open API access for integration
  • Co-authored publications
🔍

Data & Research Partners

Collaborating labs for algorithm validation, epidemiological analysis, and peer-reviewed publication pipeline.

  • Access to anonymized datasets
  • Co-authorship opportunities
  • Research infrastructure integration

What We Bring

  • Proven MVP with active pilot data

    Validated across multiple healthcare institutions

  • Technical infrastructure

    Cloud-native, API-first, WHONET-integrated platform

  • Regulatory pathway expertise

    DISHA, NCDC compliance and healthcare regulation

Partnership Timeline

Now – Q1 2026

Pilot expansion & clinical validation

Q2 2026

First peer-reviewed publications & regulatory approvals

Q3-Q4 2026

Scaled deployment across hospital network

2027+

Commercial SaaS model + government adoption